 | • レポートコード：MRC23Q36764 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の医療美容におけるボツリヌス毒素市場について調査・分析し、世界の医療美容におけるボツリヌス毒素市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（50U、100U、その他）、用途別セグメント分析（医療、化粧品）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Allergan、Ipsen、Medytox、LIBP、Merz Pharmaceuticals、US World Meds、Hugel、Daewoongなどが含まれています。世界の医療美容におけるボツリヌス毒素市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、医療美容におけるボツリヌス毒素市場規模を推定する際に考慮しました。本レポートは、医療美容におけるボツリヌス毒素の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、医療美容におけるボツリヌス毒素に関するビジネス上の意思決定に役立てることを目的としています。 ・医療美容におけるボツリヌス毒素市場の概要 - 製品の定義 - 医療美容におけるボツリヌス毒素のタイプ別セグメント - 世界の医療美容におけるボツリヌス毒素市場規模：タイプ別分析（50U、100U、その他） - 医療美容におけるボツリヌス毒素の用途別セグメント - 世界の医療美容におけるボツリヌス毒素市場規模：用途別分析（医療、化粧品） - 世界の医療美容におけるボツリヌス毒素市場規模予測（2018年-2029年） - 医療美容におけるボツリヌス毒素の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 医療美容におけるボツリヌス毒素市場の競争状況およびトレンド ・医療美容におけるボツリヌス毒素の地域別市場規模 - 北米の医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - アメリカの医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - ヨーロッパの医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - アジア太平洋の医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - 中国の医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - 日本の医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - 韓国の医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - インドの医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - オーストラリアの医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - 中南米の医療美容におけるボツリヌス毒素市場規模（2018年-2029年） - 中東・アフリカの医療美容におけるボツリヌス毒素市場規模（2018年-2029年） ・タイプ別セグメント：50U、100U、その他 - 世界の医療美容におけるボツリヌス毒素のタイプ別販売量（2018年-2023年） - 世界の医療美容におけるボツリヌス毒素のタイプ別売上（2018年-2023年） - 世界の医療美容におけるボツリヌス毒素のタイプ別価格 ・用途別セグメント：医療、化粧品 - 世界の医療美容におけるボツリヌス毒素の用途別販売量（2018年-2023年） - 世界の医療美容におけるボツリヌス毒素の用途別売上（2018年-2023年） - 世界の医療美容におけるボツリヌス毒素の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Allergan、Ipsen、Medytox、LIBP、Merz Pharmaceuticals、US World Meds、Hugel、Daewoong ・産業チェーンと販売チャネルの分析 - 医療美容におけるボツリヌス毒素産業チェーン分析 - 医療美容におけるボツリヌス毒素の主要原材料 - 医療美容におけるボツリヌス毒素の販売チャネル - 医療美容におけるボツリヌス毒素のディストリビューター - 医療美容におけるボツリヌス毒素の主要顧客 ・医療美容におけるボツリヌス毒素市場ダイナミクス - 医療美容におけるボツリヌス毒素の業界動向 - 医療美容におけるボツリヌス毒素市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Botulinum Toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin also used commercially in medicine, cosmetics.
Highlights
The global Botulinum Toxin in Medical Cosmetology market was valued at US$ 5946.9 million in 2022 and is anticipated to reach US$ 11380 million by 2029, witnessing a CAGR of 8.2% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key players of botulinum toxin in medical cosmetology include Allergan, Ipsen, Medytox, LIBP, etc. Global top five manufacturers hold a share over 93%. In terms of product, 100u is the largest segment, with a share over 34% And in terms of application, the largest application is cosmetic, with a share over 51%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botulinum Toxin in Medical Cosmetology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botulinum Toxin in Medical Cosmetology.
The Botulinum Toxin in Medical Cosmetology market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Botulinum Toxin in Medical Cosmetology market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botulinum Toxin in Medical Cosmetology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Segment by Type
50U
100U
Others
Segment by Application
Medical
Cosmetic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Botulinum Toxin in Medical Cosmetology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Botulinum Toxin in Medical Cosmetology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Botulinum Toxin in Medical Cosmetology market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botulinum Toxin in Medical Cosmetology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Botulinum Toxin in Medical Cosmetology and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Botulinum Toxin in Medical Cosmetology industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botulinum Toxin in Medical Cosmetology.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Botulinum Toxin in Medical Cosmetology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Botulinum Toxin in Medical Cosmetology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Botulinum Toxin in Medical Cosmetology Market Overview
1.1 Product Overview and Scope of Botulinum Toxin in Medical Cosmetology
1.2 Botulinum Toxin in Medical Cosmetology Segment by Type
1.2.1 Global Botulinum Toxin in Medical Cosmetology Market Value Comparison by Type (2023-2029)
1.2.2 50U
1.2.3 100U
1.2.4 Others
1.3 Botulinum Toxin in Medical Cosmetology Segment by Application
1.3.1 Global Botulinum Toxin in Medical Cosmetology Market Value by Application: (2023-2029)
1.3.2 Medical
1.3.3 Cosmetic
1.4 Global Botulinum Toxin in Medical Cosmetology Market Size Estimates and Forecasts
1.4.1 Global Botulinum Toxin in Medical Cosmetology Revenue 2018-2029
1.4.2 Global Botulinum Toxin in Medical Cosmetology Sales 2018-2029
1.4.3 Global Botulinum Toxin in Medical Cosmetology Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Botulinum Toxin in Medical Cosmetology Market Competition by Manufacturers
2.1 Global Botulinum Toxin in Medical Cosmetology Sales Market Share by Manufacturers (2018-2023)
2.2 Global Botulinum Toxin in Medical Cosmetology Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Botulinum Toxin in Medical Cosmetology Average Price by Manufacturers (2018-2023)
2.4 Global Botulinum Toxin in Medical Cosmetology Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Botulinum Toxin in Medical Cosmetology, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Botulinum Toxin in Medical Cosmetology, Product Type & Application
2.7 Botulinum Toxin in Medical Cosmetology Market Competitive Situation and Trends
2.7.1 Botulinum Toxin in Medical Cosmetology Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Botulinum Toxin in Medical Cosmetology Players Market Share by Revenue
2.7.3 Global Botulinum Toxin in Medical Cosmetology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Botulinum Toxin in Medical Cosmetology Retrospective Market Scenario by Region
3.1 Global Botulinum Toxin in Medical Cosmetology Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Botulinum Toxin in Medical Cosmetology Global Botulinum Toxin in Medical Cosmetology Sales by Region: 2018-2029
3.2.1 Global Botulinum Toxin in Medical Cosmetology Sales by Region: 2018-2023
3.2.2 Global Botulinum Toxin in Medical Cosmetology Sales by Region: 2024-2029
3.3 Global Botulinum Toxin in Medical Cosmetology Global Botulinum Toxin in Medical Cosmetology Revenue by Region: 2018-2029
3.3.1 Global Botulinum Toxin in Medical Cosmetology Revenue by Region: 2018-2023
3.3.2 Global Botulinum Toxin in Medical Cosmetology Revenue by Region: 2024-2029
3.4 North America Botulinum Toxin in Medical Cosmetology Market Facts & Figures by Country
3.4.1 North America Botulinum Toxin in Medical Cosmetology Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Botulinum Toxin in Medical Cosmetology Sales by Country (2018-2029)
3.4.3 North America Botulinum Toxin in Medical Cosmetology Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Botulinum Toxin in Medical Cosmetology Market Facts & Figures by Country
3.5.1 Europe Botulinum Toxin in Medical Cosmetology Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Botulinum Toxin in Medical Cosmetology Sales by Country (2018-2029)
3.5.3 Europe Botulinum Toxin in Medical Cosmetology Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Botulinum Toxin in Medical Cosmetology Market Facts & Figures by Country
3.6.1 Asia Pacific Botulinum Toxin in Medical Cosmetology Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Botulinum Toxin in Medical Cosmetology Sales by Country (2018-2029)
3.6.3 Asia Pacific Botulinum Toxin in Medical Cosmetology Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Botulinum Toxin in Medical Cosmetology Market Facts & Figures by Country
3.7.1 Latin America Botulinum Toxin in Medical Cosmetology Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Botulinum Toxin in Medical Cosmetology Sales by Country (2018-2029)
3.7.3 Latin America Botulinum Toxin in Medical Cosmetology Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Botulinum Toxin in Medical Cosmetology Market Facts & Figures by Country
3.8.1 Middle East and Africa Botulinum Toxin in Medical Cosmetology Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Botulinum Toxin in Medical Cosmetology Sales by Country (2018-2029)
3.8.3 Middle East and Africa Botulinum Toxin in Medical Cosmetology Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Botulinum Toxin in Medical Cosmetology Sales by Type (2018-2029)
4.1.1 Global Botulinum Toxin in Medical Cosmetology Sales by Type (2018-2023)
4.1.2 Global Botulinum Toxin in Medical Cosmetology Sales by Type (2024-2029)
4.1.3 Global Botulinum Toxin in Medical Cosmetology Sales Market Share by Type (2018-2029)
4.2 Global Botulinum Toxin in Medical Cosmetology Revenue by Type (2018-2029)
4.2.1 Global Botulinum Toxin in Medical Cosmetology Revenue by Type (2018-2023)
4.2.2 Global Botulinum Toxin in Medical Cosmetology Revenue by Type (2024-2029)
4.2.3 Global Botulinum Toxin in Medical Cosmetology Revenue Market Share by Type (2018-2029)
4.3 Global Botulinum Toxin in Medical Cosmetology Price by Type (2018-2029)
5 Segment by Application
5.1 Global Botulinum Toxin in Medical Cosmetology Sales by Application (2018-2029)
5.1.1 Global Botulinum Toxin in Medical Cosmetology Sales by Application (2018-2023)
5.1.2 Global Botulinum Toxin in Medical Cosmetology Sales by Application (2024-2029)
5.1.3 Global Botulinum Toxin in Medical Cosmetology Sales Market Share by Application (2018-2029)
5.2 Global Botulinum Toxin in Medical Cosmetology Revenue by Application (2018-2029)
5.2.1 Global Botulinum Toxin in Medical Cosmetology Revenue by Application (2018-2023)
5.2.2 Global Botulinum Toxin in Medical Cosmetology Revenue by Application (2024-2029)
5.2.3 Global Botulinum Toxin in Medical Cosmetology Revenue Market Share by Application (2018-2029)
5.3 Global Botulinum Toxin in Medical Cosmetology Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan Botulinum Toxin in Medical Cosmetology Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Ipsen
6.2.1 Ipsen Corporation Information
6.2.2 Ipsen Description and Business Overview
6.2.3 Ipsen Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ipsen Botulinum Toxin in Medical Cosmetology Product Portfolio
6.2.5 Ipsen Recent Developments/Updates
6.3 Medytox
6.3.1 Medytox Corporation Information
6.3.2 Medytox Description and Business Overview
6.3.3 Medytox Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medytox Botulinum Toxin in Medical Cosmetology Product Portfolio
6.3.5 Medytox Recent Developments/Updates
6.4 LIBP
6.4.1 LIBP Corporation Information
6.4.2 LIBP Description and Business Overview
6.4.3 LIBP Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LIBP Botulinum Toxin in Medical Cosmetology Product Portfolio
6.4.5 LIBP Recent Developments/Updates
6.5 Merz Pharmaceuticals
6.5.1 Merz Pharmaceuticals Corporation Information
6.5.2 Merz Pharmaceuticals Description and Business Overview
6.5.3 Merz Pharmaceuticals Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merz Pharmaceuticals Botulinum Toxin in Medical Cosmetology Product Portfolio
6.5.5 Merz Pharmaceuticals Recent Developments/Updates
6.6 US World Meds
6.6.1 US World Meds Corporation Information
6.6.2 US World Meds Description and Business Overview
6.6.3 US World Meds Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.6.4 US World Meds Botulinum Toxin in Medical Cosmetology Product Portfolio
6.6.5 US World Meds Recent Developments/Updates
6.7 Hugel
6.6.1 Hugel Corporation Information
6.6.2 Hugel Description and Business Overview
6.6.3 Hugel Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hugel Botulinum Toxin in Medical Cosmetology Product Portfolio
6.7.5 Hugel Recent Developments/Updates
6.8 Daewoong
6.8.1 Daewoong Corporation Information
6.8.2 Daewoong Description and Business Overview
6.8.3 Daewoong Botulinum Toxin in Medical Cosmetology Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Daewoong Botulinum Toxin in Medical Cosmetology Product Portfolio
6.8.5 Daewoong Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Botulinum Toxin in Medical Cosmetology Industry Chain Analysis
7.2 Botulinum Toxin in Medical Cosmetology Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Botulinum Toxin in Medical Cosmetology Production Mode & Process
7.4 Botulinum Toxin in Medical Cosmetology Sales and Marketing
7.4.1 Botulinum Toxin in Medical Cosmetology Sales Channels
7.4.2 Botulinum Toxin in Medical Cosmetology Distributors
7.5 Botulinum Toxin in Medical Cosmetology Customers
8 Botulinum Toxin in Medical Cosmetology Market Dynamics
8.1 Botulinum Toxin in Medical Cosmetology Industry Trends
8.2 Botulinum Toxin in Medical Cosmetology Market Drivers
8.3 Botulinum Toxin in Medical Cosmetology Market Challenges
8.4 Botulinum Toxin in Medical Cosmetology Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
